Invention Grant
- Patent Title: HCV NS3 protease inhibitors
- Patent Title (中): HCV NS3蛋白酶抑制剂
-
Application No.: US11919783Application Date: 2006-04-28
-
Publication No.: US07879797B2Publication Date: 2011-02-01
- Inventor: M. Katharine Holloway , Nigel J. Liverton , Steven W. Ludmerer , John A. McCauley , David Olsen , Michael T. Rudd , Joseph P. Vacca
- Applicant: M. Katharine Holloway , Nigel J. Liverton , Steven W. Ludmerer , John A. McCauley , David Olsen , Michael T. Rudd , Joseph P. Vacca
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Sheldon O. Heber; Julie M. Lake
- International Application: PCT/US2006/016343 WO 20060428
- International Announcement: WO2006/119061 WO 20061109
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Public/Granted literature
- US20090075869A1 HCV NS3 protease inhibitors Public/Granted day:2009-03-19
Information query
IPC分类:
